MicroRNA-541 promotes the proliferation of vascular smooth muscle cells by targeting IRF7

American Journal of Translational Research

Volumn 8, Issue 2, 2016, Pages 506-515

  Yang, Fang ^a   Xu, Zonglei ^b   Duan, Shaobin ^c   Luo, Min ^c  

^a YANTAISHAN HOSPITAL   (China)

^b LIAOCHENG PEOPLE'S HOSPITAL   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

IRF7; MicroRNA; MiR 541; Vascular smooth muscle cells

Indexed keywords

INTERFERON REGULATORY FACTOR 7; MICRORNA; MICRORNA 541; PLATELET DERIVED GROWTH FACTOR BB; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; OPTICAL DENSITY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SERUM; UPREGULATION; VASCULAR SMOOTH MUSCLE CELL; WESTERN BLOTTING;

EID: 84962107072     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Yu X and Li Z. MicroRNAs regulate vascular smooth muscle cell functions in atherosclerosis (review). Int J Mol Med 2014; 34: 923-933.
2. Cheng Y, Liu X, Yang J, Lin Y, Xu DZ, Lu Q, Deitch EA, Huo Y, Delphin ES and Zhang C. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res 2009; 105: 158-166.
3. Wang YS, Wang HY, Liao YC, Tsai PC, Chen KC, Cheng HY, Lin RT and Juo SH. MicroRNA-195 regulates vascular smooth muscle cell phenotype and prevents neointimal formation. Cardiovasc Res 2012; 95: 517-526.
4. Kim MH, Ham O, Lee SY, Choi E, Lee CY, Park JH, Lee J, Seo HH, Seung M, Min PK and Hwang KC. MicroRNA-365 Inhibits the Proliferation of Vascular Smooth Muscle Cells by Targeting Cyclin D1. J Cell Biochem 2014; 115: 1752-61.
5. Li P, Liu Y, Yi B, Wang G, You X, Zhao X, Summer R, Qin Y and Sun J. MicroRNA-638 is highly expressed in human vascular smooth muscle cells and inhibits PDGF-BB-induced cell proliferation and migration through targeting orphan nuclear receptor NOR1. Cardiovasc Res 2013; 99: 185-193.
6. Chan MC, Hilyard AC, Wu C, Davis BN, Hill NS, Lal A, Lieberman J, Lagna G and Hata A. Molecular basis for antagonism between PDGF and the TGFbeta family of signalling pathways by control of miR-24 expression. EMBO J 2010; 29: 559-573.
7. Zhang Y, Wang Y, Wang X, Eisner GM, Asico LD, Jose PA and Zeng C. Insulin promotes vascular smooth muscle cell proliferation via microRNA-208-mediated downregulation of p21. J Hypertens 2011; 29: 1560-1568.
8. Song L, Duan P, Guo P, Li D, Li S, Xu Y and Zhou Q. Downregulation of miR-223 and miR-153 mediates mechanical stretch-stimulated proliferation of venous smooth muscle cells via activation of the insulin-like growth factor-1 receptor. Arch Biochem Biophys 2012; 528: 204-211.
9. Li M, Yu M, Liu C, Zhu H, He X, Peng S and Hua J. miR-34c works downstream of p53 leading to dairy goat male germline stem-cell (mGSCs) apoptosis. Cell Prolif 2013; 46: 223-231.
10. Lee JE, Hong EJ, Nam HY, Kim JW, Han BG and Jeon JP. MicroRNA signatures associated with immortalization of EBV-transformed lymphoblastoid cell lines and their clinical traits. Cell Prolif 2011; 44: 59-66.
11. Ohdaira H, Sekiguchi M, Miyata K and Yoshida K. MicroRNA-494 suppresses cell proliferation and induces senescence in A549 lung cancer cells. Cell Prolif 2012; 45: 32-38.
12. Li J, You T and Jing J. MiR-125b inhibits cell biological progression of Ewing’s sarcoma by suppressing the PI3K/Akt signalling pathway. Cell Prolif 2014; 47: 152-160.
13. Mun J, Tam C, Chan G, Kim JH, Evans D and Fleiszig S. MicroRNA-762 is upregulated in human corneal epithelial cells in response to tear fluid and Pseudomonas aeruginosa antigens and negatively regulates the expression of host defense genes encoding RNase7 and ST2. PLoS One 2013; 8: e57850.
14. Li R, Yuan W, Mei W, Yang K and Chen Z. MicroRNA 520d-3p inhibits gastric cancer cell proliferation, migration, and invasion by downregulating EphA2 expression. Mol Cell Biochem 2014; 396: 295-305.
15. Cesana M, Cacchiarelli D, Legnini I, Santini T, Sthandier O, Chinappi M, Tramontano A and Bozzoni I. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 2011; 147: 358-369.
16. Nishioka C, Ikezoe T, Yang J, Nobumoto A, Tsuda M and Yokoyama A. Downregulation of miR-217 correlates with resistance of ph leukemia cells to ABL tyrosine kinase inhibitors. Cancer Sci 2014 105: 297-307.
17. Kong D, Piao YS, Yamashita S, Oshima H, Oguma K, Fushida S, Fujimura T, Minamoto T, Seno H, Yamada Y, Satou K, Ushijima T, Ishikawa TO and Oshima M. Inflammation-induced repression of tumor suppressor miR-7 in gastric tumor cells. Oncogene 2012; 31: 3949-3960.
18. Weber DG, Johnen G, Bryk O, Jockel KH and Bruning T. Identification of miRNA-103 in the cellular fraction of human peripheral blood as a potential biomarker for malignant mesothelioma--a pilot study. PLoS One 2012; 7: e30221.
19. Zhong X, Chung AC, Chen HY, Dong Y, Meng XM, Li R, Yang W, Hou FF and Lan HY. miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes. Diabetologia 2013; 56: 663-674.
20. Wang J, Yan CH, Li Y, Xu K, Tian XX, Peng CF, Tao J, Sun MY and Han YL. MicroRNA-31 controls phenotypic modulation of human vascular smooth muscle cells by regulating its target gene cellular repressor of E1A-stimulated genes. Exp Cell Res 2013; 319: 1165-1175.
21. Kim S and Kang H. miR-15b induced by platelet-derived growth factor signaling is required for vascular smooth muscle cell proliferation. BMB Rep 2013; 46: 550-554.
22. Gao S, Wassler M, Zhang L, Li Y, Wang J, Zhang Y, Shelat H, Williams J and Geng YJ. MicroRNA-133a regulates insulin-like growth factor-1 receptor expression and vascular smooth muscle cell proliferation in murine atherosclerosis. Atherosclerosis 2014; 232: 171-179.
23. Yu ML, Wang JF, Wang GK, You XH, Zhao XX, Jing Q and Qin YW. Vascular smooth muscle cell proliferation is influenced by let-7d microRNA and its interaction with KRAS. Circ J 2011; 75: 703-709.
24. Li J, Zhao L, He X, Yang T and Yang K. MiR-21 inhibits c-Ski signaling to promote the proliferation of rat vascular smooth muscle cells. Cell Signal 2014; 26: 724-729.
25. Sun Y, Chen D, Cao L, Zhang R, Zhou J, Chen H, Li Y, Li M, Cao J and Wang Z. MiR-490-3p modulates the proliferation of vascular smooth muscle cells induced by ox-LDL through targeting PAPP-A. Cardiovasc Res 2013; 100: 272-279.
26. Kee HJ, Park S, Kwon JS, Choe N, Ahn Y, Kook H and Jeong MH. B cell translocation gene, a direct target of miR-142-5p, inhibits vascular smooth muscle cell proliferation by down-regulating cell cycle progression. FEBS Lett 2013; 587: 2385-2392.
27. Sun SG, Zheng B, Han M, Fang XM, Li HX, Miao SB, Su M, Han Y, Shi HJ and Wen JK. miR-146a and Kruppel-like factor 4 form a feedback loop to participate in vascular smooth muscle cell proliferation. EMBO Rep 2011; 12: 56-62.
28. Liu X, Cheng Y, Zhang S, Lin Y, Yang J and Zhang C. A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res 2009; 104: 476-487.
29. Wen P, Cao H, Fang L, Ye H, Zhou Y, Jiang L, Su W, Xu H, He W, Dai C and Yang J. miR-125b/ Ets1 axis regulates transdifferentiation and calcification of vascular smooth muscle cells in a high-phosphate environment. Exp Cell Res 2014; 322: 302-312.
30. Li Z, Yu X, Wang Y, Shen J, Wu WK, Liang J and Feng F. By downregulating TIAM1 expression, microRNA-329 suppresses gastric cancer invasion and growth. Oncotarget 2015; 6: 17559-69.
31. Stein JJ, Iwuchukwu C, Maier KG and Gahtan V. Thrombospondin-1-induced vascular smooth muscle cell migration and proliferation are functionally dependent on microRNA-21. Surgery 2014; 155: 228-233.
32. Liu F, Li N, Long B, Fan YY, Liu CY, Zhou QY, Murtaza I, Wang K and Li PF. Cardiac hypertrophy is negatively regulated by miR-541. Cell Death Dis 2014; 5: e1171.
33. Leivonen SK, Sahlberg KK, Makela R, Due EU, Kallioniemi O, Borresen-Dale AL and Perala M. High-throughput screens identify microRNAs essential for HER2 positive breast cancer cell growth. Mol Oncol 2014; 8: 93-104.
34. Edwards CL, Best SE, Gun SY, Claser C, James KR, de Oca MM, Sebina I, de Labastida Rivera F, Amante FH, Hertzog PJ, Engwerda CR, Renia L and Haque A. Spatio-temporal requirements for IRF7 in mediating type I IFN-dependent susceptibility to blood-stage Plasmodium infection. Eur J Immunol 2015; 45: 130-141.
35. Zhou P, Cowled C, Mansell A, Monaghan P, Green D, Wu L, Shi Z, Wang LF and Baker ML. IRF7 in the Australian black flying fox, Pteropus alecto: evidence for a unique expression pattern and functional conservation. PLoS One 2014; 9: e103875.
36. Love AC, Schwartz I and Petzke MM. Borrelia burgdorferi RNA induces type I and III interferons via Toll-like receptor 7 and contributes to production of NF-kappaB-dependent cytokines. Infect Immun 2014; 82: 2405-2416.
37. Kim N, Kukkonen S, Martinez-Viedma Mdel P, Gupta S and Aldovini A. Tat engagement of p38 MAP kinase and IRF7 pathways leads to activation of interferon-stimulated genes in antigen-presenting cells. Blood 2013; 121: 4090-4100.
38. Ning S, Huye LE and Pagano JS. Regulation of the transcriptional activity of the IRF7 promoter by a pathway independent of interferon signaling. J Biol Chem 2005; 280: 12262-12270.
39. Huang L, Zhang SM, Zhang P, Zhang XJ, Zhu LH, Chen K, Gao L, Zhang Y, Kong XJ, Tian S, Zhang XD and Li H. Interferon regulatory factor 7 protects against vascular smooth muscle cell proliferation and neointima formation. J Am Heart Assoc 2014; 3: e001309.